Many adults reach a point where the usual formula stops working. They eat carefully, exercise consistently, and stay disciplined, yet their weight holds steady or creeps upward. Energy fades. The common assumption is that more effort is needed.
That assumption is often wrong. Stalled progress is rarely a willpower failure. More often, it reflects a metabolic shift that a standard annual physical is not designed to detect.
The scale of the problem is significant. An analysis of national NHANES data by researchers at the UNC Gillings School found that only 12.2% of American adults (about 27.3 million people) met the criteria for metabolic health across waist circumference, blood glucose, blood pressure, triglycerides, and HDL cholesterol.
Metabolic health testing explains stalled progress in a way a glucose-only physical cannot. This article covers three topics:
- The insulin resistance compensation pattern
- The American Heart Association’s cardiovascular-kidney-metabolic (CKM) staging framework
- Why these markers require clinical interpretation rather than a do-it-yourself panel
The Annual Physical Was Never Built to Catch This
A typical annual physical checks fasting glucose, a basic lipid panel, blood pressure, and weight or BMI. These tests are useful, but they are built to identify disease once it is present. They are not built to track the years-long metabolic drift that precedes a diagnosis.
Weight alone is also a poor guide. The same research found that less than 1% of adults with obesity were metabolically healthy. Only about one-third of normal-weight adults qualified either. A “healthy” number on the scale does not confirm a healthy metabolism.
The most important omission is fasting insulin. It is arguably the single most informative early-warning marker, yet it is almost never included in routine bloodwork.
The Insulin Resistance Compensation Pattern: Why Normal Glucose Can Be a False Reassurance
When cells begin to resist insulin’s signal, the pancreas compensates by producing more insulin to move glucose into cells. Because this compensation works, blood glucose can stay in the normal range for years while insulin levels quietly climb.
A passing glucose result therefore does not rule out insulin resistance.
This matters for anyone facing a plateau. Elevated insulin promotes fat storage and blunts the body’s ability to burn fat. As a result, strategies that once worked can stop producing results.
By the time glucose rises into the prediabetic or diabetic range, insulin resistance has usually been present for years. The standard physical detects the endpoint, not the process.
How Common, and How Hidden, This Pattern Really Is
According to the CDC:
- About 115 million U.S. adults have prediabetes. That is far more than the roughly 40 million Americans (about 12% of the population) with diabetes.
- About 8 in 10 adults with prediabetes do not know they have it.
- The risk grows with age. More than half of adults 65 and older (52.1%) have prediabetes.
Metabolic syndrome is also widespread. A JAMA analysis of 2013 to 2023 NHANES data found a weighted prevalence of 38.7% among U.S. adults. Rates climb from about 22.2% in adults aged 20 to 39 to 56.4% in those 60 and older.
Roughly one in three Americans carries three or more risk factors spanning cardiovascular, metabolic, and kidney health, often without any formal diagnosis. Many people feel fine while dysfunction is already underway.
A New Clinical Framework: The AHA’s Cardiovascular-Kidney-Metabolic (CKM) Staging System
In October 2023, the American Heart Association published a presidential advisory in Circulation that formally defined cardiovascular-kidney-metabolic (CKM) syndrome.
The framework stages risk on a continuum:
- Stage 0: no risk factors, with the focus on prevention
- Stage 4: advanced disease, which may include kidney failure
The framework treats heart, kidney, and metabolic health as interconnected systems rather than separate silos. Major medical authorities now view metabolic risk as a staged, multi-organ continuum, not a single pass-or-fail glucose or cholesterol number. A standard physical built around isolated thresholds is not structured to place a patient on that continuum.
The Markers a Standard Physical Leaves Out
Each of the following markers reveals something that glucose alone cannot.
Fasting Insulin
Fasting insulin is the earliest detectable signal of the compensation pattern. It can be abnormal years, or even decades, before glucose shifts.
Commonly referenced ranges place optimal levels below 8 µIU/mL. Values above 10 µIU/mL suggest early insulin resistance. These figures are reference points for clinical interpretation, not for self-diagnosis.
HOMA-IR: Turning Two Numbers Into One Insight
HOMA-IR is a calculated index that combines two fasting values:
HOMA-IR = (fasting insulin × fasting glucose) / 405
Its value lies in what it reveals together. HOMA-IR can quantify insulin resistance even when each individual value looks unremarkable on its own.
The Triglyceride-to-HDL Ratio
The TG/HDL ratio is a low-cost, widely studied surrogate for insulin resistance. It can be calculated from numbers that already appear on a standard lipid panel. A ratio of 3 or higher is closely correlated with insulin resistance, yet it is rarely calculated or flagged during a routine physical.
Inflammatory and Metabolic Syndrome Markers
Inflammatory markers such as CRP add further context, as does the classic metabolic syndrome cluster:
- Abdominal obesity
- Elevated blood pressure
- High fasting glucose
- Elevated triglycerides
- Low HDL
No single marker tells the full story. These values have to be read together.
Why More Data Isn’t the Same as a Diagnosis
Direct-to-consumer biomarker platforms and continuous glucose monitors (CGMs) reflect growing public awareness of this testing gap. The evidence behind them, however, calls for balance.
Two 2025 systematic reviews found that CGM data in non-diabetic individuals were too scarce and inconsistent to show clear cardiovascular outcome benefits. The effects also varied by population: people with prediabetes saw measurable glycemic improvements, while already-healthy users mainly gained general awareness.
More numbers do not explain root cause or produce a corrective plan. A persistent plateau is often a problem of how markers interact. Examples include normal glucose paired with elevated insulin, or inflammation that disrupts leptin signaling and worsens insulin resistance. A self-ordered panel is not built to resolve those patterns on its own.
From Diagnosis to Direction: Why This Requires Clinical Interpretation
The real value of metabolic testing comes from reading the markers together, as the CKM framework intends. Those markers include:
- Insulin
- Glucose
- TG/HDL ratio
- Inflammatory signals
- Blood pressure
- Waist circumference
Interpreting them is a clinical skill. It involves identifying where a patient sits on the continuum, which marker moved first, and whether the pattern reflects early compensation or established dysfunction.
Red Mountain, a clinically led practice with more than 30 years of patient outcomes and in-person providers, builds metabolic assessment and initial labs into the Foundation stage of care. The goal is to answer the question patients actually bring: “Why isn’t what I’m doing working anymore?”
Findings then shape a supervised corrective plan. That plan may include nutrition strategy, structured monitoring, and, when clinically appropriate, medical weight loss support such as GLP-1 medication. Medication is one supervised tool within a broader structure of clinical guidance, never a standalone fix.
Conclusion: Reframing the Question for the Next Checkup
A clean annual physical does not guarantee metabolic health. It may simply mean the right markers were never tested.
Normal glucose can coexist with rising insulin for years. For that reason, a plateau deserves a deeper look rather than more willpower.
The CKM framework points toward the emerging standard: metabolic risk understood as a staged, multi-organ continuum. Identifying the pattern is only half the work. Interpreting how markers interact and building a corrective plan is a clinical task, not a self-service one.
Next Step: Getting a Clearer Picture of Metabolic Health
For anyone who recognizes the “why isn’t this working” feeling, a clinical consult is usually the logical next step. This is the kind of question Red Mountain’s providers explain in consults. The conversation is informational, focused on answers and a supervised plan rather than a commitment to any product.
Understanding what is actually happening metabolically is the starting point for sustainable, long-term correction.
